文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

中性粒细胞靶向脂质纳米颗粒递送PD-L1 siRNA有效改善脓毒症

THE DELIVERY OF PD-L1 SIRNA BY NEUTROPHIL-TARGETED LIPID NANOPARTICLES EFFECTIVELY AMELIORATES SEPSIS.
PubMed 文献 · Shock · 2024-08-12
一句话结论中性粒细胞靶向脂质纳米颗粒递送PD-L1 siRNA在脓毒症小鼠中抑制炎症、减少中性粒细胞胞外诱捕网释放并减轻多器官损伤。

脓毒症影响全球超过4800万人,中性粒细胞表面程序性死亡配体1(PD-L1)参与脓毒症炎症器官功能障碍和免疫麻痹,但体内特异性靶向中性粒细胞PD-L1的策略匮乏。作者开发了两种通过中性粒细胞特异性抗体和多肽递送PD-L1 siRNA的中性粒细胞靶向脂质纳米颗粒,并进行体内外实验检测其进入中性粒细胞。采用小鼠盲肠结扎穿孔模型检测中性粒细胞迁移、中性粒细胞胞外诱捕网水平和器官损伤。结果显示,靶向中性粒细胞的PD-L1 siRNA负载脂质纳米颗粒抑制炎症、减少中性粒细胞胞外诱捕网释放、抑制T淋巴细胞凋亡,有助于维持脓毒症期间免疫和炎症反应稳态,并可能减轻盲肠结扎穿孔导致的多器官损伤和致死性。

要点

  • 中性粒细胞表面PD-L1参与脓毒症炎症器官功能障碍和免疫麻痹,但体内特异性靶向中性粒细胞PD-L1的策略匮乏。
  • 作者开发两种中性粒细胞靶向脂质纳米颗粒,分别通过中性粒细胞特异性抗体和多肽递送PD-L1 siRNA。
  • 在小鼠盲肠结扎穿孔模型中,PD-L1 siRNA负载脂质纳米颗粒抑制炎症、减少中性粒细胞胞外诱捕网释放、抑制T淋巴细胞凋亡。
  • 该策略有助于维持脓毒症期间免疫和炎症反应稳态,并可能减轻盲肠结扎穿孔导致的多器官损伤和致死性。
  • 作者认为该中性粒细胞靶向药物递送策略是脓毒症治疗的新颖、安全且有效的方法。

适用人群与场景

  • 脓毒症小鼠盲肠结扎穿孔模型

研究设计与关键结果

  • 研究类型:基础研究(脂质纳米颗粒递送系统开发与小鼠体内外实验)。
  • 干预:两种中性粒细胞靶向脂质纳米颗粒,分别通过中性粒细胞特异性抗体和多肽递送PD-L1 siRNA。
  • 模型:小鼠盲肠结扎穿孔模型,检测中性粒细胞迁移、中性粒细胞胞外诱捕网水平和器官损伤。
  • 结果:PD-L1 siRNA负载脂质纳米颗粒抑制炎症、减少中性粒细胞胞外诱捕网释放、抑制T淋巴细胞凋亡。
  • 结果:该策略有助于维持脓毒症期间免疫和炎症反应稳态,并可能减轻盲肠结扎穿孔导致的多器官损伤和致死性。

证据类型、等级与局限

  • 证据类型:基础研究(脂质纳米颗粒递送系统开发与小鼠体内外实验)。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为该中性粒细胞靶向药物递送策略是脓毒症治疗的新颖、安全且有效的方法。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: Sepsis, a complex and life-threatening disease, poses a significant global burden affecting over 48 million individuals. Recently, it has been reported that programmed death-ligand 1 (PD-L1) expressed on neutrophils is involved in both inflammatory organ dysfunction and immunoparalysis in sepsis. However, there is a dearth of strategies to specifically target PD-L1 in neutrophils in vivo . Methods: We successfully developed two lipid nanoparticles (LNPs) specifically targeting neutrophils by delivering PD-L1 siRNA via neutrophil-specific antibodies and polypeptides. In vivo and in vitro experiments were performed to detect lipid nanoparticles into neutrophils. A mouse cecal ligation and puncture model was used to detect neutrophil migration, neutrophil extracellular traps level, and organ damage. Result: The PD-L1 siRNA-loaded LNPs that target neutrophils suppressed inflammation, reduced the release of neutrophil extracellular traps, and inhibited T-lymphocyte apoptosis. This approach could help maintain homeostasis of both the immune and inflammatory responses during sepsis. Furthermore, the PD-L1 siRNA-loaded LNPs targeting neutrophils have the potential to ameliorate the multiorgan damage and lethality resulting from cecal ligation and puncture. Conclusions: Taken together, our data identify a previously unknown drug delivery strategy targeting neutrophils, which represents a novel, safe, and effective approach to sepsis therapy.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Zhu CL, Wang Y, Ren SC, et al. THE DELIVERY OF PD-L1 SIRNA BY NEUTROPHIL-TARGETED LIPID NANOPARTICLES EFFECTIVELY AMELIORATES SEPSIS. Shock. 2024. PMID: 39158541. doi:10.1097/SHK.0000000000002450

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。